Cargando…

Immunological response after mild COVID-19: How long will it last?

Detalles Bibliográficos
Autor principal:	Balduzzi, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460323/ https://www.ncbi.nlm.nih.gov/pubmed/34563925 http://dx.doi.org/10.1016/j.ebiom.2021.103597

Ejemplares similares

Mitral valve repair or replacement. How long is this feud to last?
por: Di Mauro, Michele, et al.
Publicado: (2022)

Antibody responses in mild COVID-19 hospital staff
por: Plebani, Mario
Publicado: (2020)

Education in and After Covid-19: Immediate Responses and Long-Term Visions
por: Zhu, Xudong, et al.
Publicado: (2020)

How the metabolic phenotype in adulthood is affected by long-lasting immunological trajectories since adolescence
por: Barroso, Isaac, et al.
Publicado: (2022)

Cilia develop long-lasting contacts, with other cilia
por: Jackson, Peter K
Publicado: (2012)

The Course of Mild and Moderate COVID-19 Infections—The Unexpected Long-Lasting Challenge
por: Xia, Lu, et al.
Publicado: (2020)

Reimagining laboratory‐based immunology education in the time of COVID‐19
por: Wilkinson, Thomas S., et al.
Publicado: (2021)

The COVID-19 Response in Nebraska: How Students Answered the Call
por: Chengane, Sabrine, et al.
Publicado: (2020)

Response to “How prepared is Africa to face COVID-19?” by Wadoum and Clarke
por: Awoonor-Williams, John Koku, et al.
Publicado: (2020)

Ring Pressure Sign: When Long Lasting Dermoscopic Observation Leads the Decision
por: Piccolo, Vincenzo, et al.
Publicado: (2021)

Home versus institutional isolation of mild COVID-19 patients
por: Christopher, Devasahayam Jesudas, et al.
Publicado: (2021)

Severe and long‐lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID‐19: A case report
por: Jozuka, Ryosuke, et al.
Publicado: (2021)

Long-Lasting Cognitive Abnormalities after COVID-19
por: Ferrucci, Roberta, et al.
Publicado: (2021)

Long lasting hypercoagulability after subclinical COVID-19
por: Ferroli, Paolo, et al.
Publicado: (2020)

Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors?
por: Motiejunaite, Justina, et al.
Publicado: (2021)

Continued use of azithromycin for mild COVID-19 in India: Evidence and implications?
por: Atal, Shubham, et al.
Publicado: (2021)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

How important are COVID-19 vaccine responses in patients with MS on disease-modifying therapies?
por: Giovannoni, Gavin
Publicado: (2022)

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
por: Bolze, Alexandre, et al.
Publicado: (2022)

Coverage enhancement and community empowerment via commercial availability of the long-lasting nets for malaria in India
por: Rahi, Manju, et al.
Publicado: (2021)

Key social science priorities for long-term COVID-19 response
por: Lees, Shelley, et al.
Publicado: (2021)

Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases
por: Li, Qian, et al.
Publicado: (2022)

How health workers can make a difference in the public COVID-19 vaccination response
por: Habersaat, Katrine B., et al.
Publicado: (2022)

Commentary: Nothing lasts forever
por: Mainwaring, Richard D.
Publicado: (2021)

Commentary: It looks good, but will it last?
por: Eikelboom, Rachel, et al.
Publicado: (2020)

CMA: how long does it last for?
por: Papadopoulos, Nikolaos
Publicado: (2011)

How long do antiprotons last?
por: Eades, John
Publicado: (1993)

Uncertainty and COVID-19: how are we to respond?
por: Koffman, Jonathan, et al.
Publicado: (2020)

How prepared is Africa to face COVID-19?
por: Wadoum, Raoul Emeric Guetiya, et al.
Publicado: (2020)

Antibiotics in childhood pneumonia: how long is long enough?
por: Grimwood, Keith, et al.
Publicado: (2016)

Immunological and inflammatory profiles in mild and severe cases of COVID-19
por: Song, Jin-Wen, et al.
Publicado: (2020)

A Failure to Communicate? How Public Messaging Has Strained the COVID-19 Response in the United States
por: Sauer, Molly A., et al.
Publicado: (2021)

Who is responsible for global health inequalities after Covid-19?
por: Winsberg, Eric
Publicado: (2022)

COVID-19 vaccines and vaccination: how prepared is Africa?
por: Ariyo, Olumuyiwa Elijah, et al.
Publicado: (2021)

Antibody tests for diagnosing COVID-19: how relevant are they?
por: Shey, Muki Shehu, et al.
Publicado: (2020)

How Was Kidney Care Reshaped by the COVID-19 Pandemic?
por: Soares dos Santos Junior, Augusto Cesar
Publicado: (2022)

How to operationalise human rights for COVID-19 measures
por: Hostmaelingen, Njal, et al.
Publicado: (2020)

Increasing fetal hemoglobin as a possible key for improvement of hypoxia and saving last breath in COVID-19 patient: “postulating a hypothesis”
por: Abdelzaher, Muhamed A., et al.
Publicado: (2021)

Normal antibody response after COVID-19 during treatment with cladribine
por: Celius, Elisabeth G.
Publicado: (2020)

Long term consequences of COVID-19
por: Berenguera, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_adevl3rlm5ia93c43c21noccln